BMI View: The launch of Côte d’Ivoire’s universal healthcare scheme will improve much of the
population’s access to medicines and drive the demand for pharmaceuticals in the country. Its geographical
proximity to Ebola-stricken Liberia and Guinea has seen the West African country be the beneficiary of aid
donations which should assist in the strengthening of Côte d’Ivoire’s health services. We highlight low
affordability levels among the population as a barrier to healthcare access.
Headline Expenditure Projections
? Pharmaceuticals: XOF250.49bn (USD512mn) in 2014 to XOF269.96bn (USD514mn) in 2015; +7.8%
in local currency terms and +0.5% in US dollar terms. Forecast broadly in line with our previous
estimate for Q115.
? Healthcare: XOF1,112bn (USD2.27bn) in 2014 to XOF1,242.15bn (USD2.37bn) in 2015; +11.7% in
local currency terms and +4.2% in US dollar terms. Forecast in line with Q115.

Table of Contents

BMI Industry View 7
SWOT 9
Political 10
Economic 11
Operational Risk 12
Industry Forecast 15
Pharmaceutical Market Forecast 15
Table: Pharmaceutical Sales, Historical Data And Forecasts (Cote d`Ivoire 2011-2019) 16
Healthcare Market Forecast 17
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Cote d`Ivoire 2011-2019) 20
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Cote d`Ivoire 2011-2019) 20
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Cote d`Ivoire 2011-2019) 21
Pharmaceutical Trade Forecast 21
Macroeconomic Forecasts 24
Table: Economic Activity (Cote d`Ivoire 2011-2020) 28
Industry Risk Reward Indicies 29
Middle East And Africa Risk/Reward Index 29
Côte d'Ivoire Risk/Reward Index 37
Rewards 37
Risks 38
Market Overview 39
Industry Trends And Developments 43
Epidemiology 43
Healthcare Sector 46
Regulatory Development 49
Competitive Landscape 53
Domestic Industry 53
Foreign Industry 54
Demographic Forecast 57
Table: Population Headline Indicators (Cote d`Ivoire 1990-2025) 58
Table: Key Population Ratios (Cote d`Ivoire 1990-2025) 58
Table: Urban/Rural Population & Life Expectancy (Cote d`Ivoire 1990-2025) 59
Table: Population By Age Group (Cote d`Ivoire 1990-2025) 59
Table: Population By Age Group % (Cote d`Ivoire 1990-2025) 60
Glossary 62
Methodology 64
Pharmaceutical Expenditure Forecast Model 64
Healthcare Expenditure Forecast Model 64
Notes On Methodology 65
Risk/Reward Index Methodology 66
Index Overview 67
Table: Pharmaceutical Risk/Reward Index Indicators 67
Indicator Weightings 68

List of Tables

Table: Pharmaceutical Sales, Historical Data And Forecasts (Cote d`Ivoire 2011-2019)
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Cote d`Ivoire 2011-2019)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Cote d`Ivoire 2011-2019)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Cote d`Ivoire 2011-2019)
Table: Economic Activity (Cote d`Ivoire 2011-2020)
Table: Population Headline Indicators (Cote d`Ivoire 1990-2025)
Table: Key Population Ratios (Cote d`Ivoire 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Cote d`Ivoire 1990-2025)
Table: Population By Age Group (Cote d`Ivoire 1990-2025)
Table: Population By Age Group % (Cote d`Ivoire 1990-2025)
Table: Pharmaceutical Risk/Reward Index Indicators